Poschke et al. demonstrated in stage IV melanoma patients that the presence of CD14+HLA-DRlo/neg cells purified with elutriated monocytes negatively impacted the maturation, migration, antigen uptake, and cytokine production of DCs (73). Here, CD14 is linked to melanoma.